[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Kenneth Sadowsky, a director of Vita Coco Company, Inc., sold 3,900 shares of common stock on 09/17/2025 under a Rule 10b5-1 trading plan at a weighted average price of $40.034 (individual trade prices ranged from $39.65 to $40.22). After the sale he beneficially owned 623,866 shares. The filing also discloses a fully vested, currently exercisable non-qualified stock option covering 27,300 underlying shares with a $10.178 exercise price. The Form 4 was filed by an attorney-in-fact on behalf of the reporting person and identifies the sale as pre-arranged under Rule 10b5-1.

Positive

• Sale executed under a Rule 10b5-1 plan, indicating a pre-arranged trade rather than opportunistic insider timing.
• Reporting person retains substantial ownership with 623,866 shares beneficially owned after the sale.
• Holds fully vested, exercisable options for 27,300 underlying shares at a $10.178 exercise price.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine, pre-planned insider sale; maintains substantial ongoing ownership and holds vested options.

The sale of 3,900 shares pursuant to a Rule 10b5-1 plan signals a pre-arranged disposition rather than an opportunistic, ad hoc insider trade. The reporting person remains a significant shareholder with 623,866 shares post-transaction, which supports continuity of insider alignment with shareholders. Disclosure of a fully vested, exercisable option for 27,300 shares at a $10.178 strike highlights future potential for share issuance if exercised, but the filing provides no exercise or expiration dates beyond the vesting/exercisability statement. Overall, governance disclosure is standard and compliant.

Securities Analyst

TL;DR: Small-sized sale using a Rule 10b5-1 plan; no material change to ownership or control.

The transaction size (3,900 shares) is small relative to the remaining beneficial ownership (623,866 shares) and was executed under a Rule 10b5-1 plan, reducing concerns about opportunistic timing. The weighted average sale price reported is $40.034 with individual trades between $39.65 and $40.22. The disclosure of 27,300 underlying shares subject to fully vested, exercisable options at a $10.178 strike is relevant for potential dilution analysis, but the filing does not indicate imminent exercises. From a market-impact perspective, this Form 4 reflects routine insider liquidity rather than a material event.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sadowsky Kenneth

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		S(1)		3,900	D	$40.034(2)	623,866	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(3)	01/02/2030	Common Stock	27,300		27,300	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.65 to $40.22, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The stock option is fully vested and currently exercisable.

	By: Alison Klein, Attorney-in-Fact For: Kenneth Sadowsky	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Kenneth Sadowsky (COCO) report on the Form 4?

He reported a sale of 3,900 shares on 09/17/2025 under a Rule 10b5-1 trading plan and disclosed ownership of 623,866 shares plus vested options.

At what price were the COCO shares sold by the insider?

Weighted average price $40.034; individual trade prices ranged from $39.65 to $40.22 as disclosed in the filing.

How many shares does the insider own after the reported sale?

623,866 shares beneficially owned following the reported transaction.

Does the Form 4 disclose any stock options for the reporting person?

Yes. A non-qualified stock option covering 27,300 underlying shares at a $10.178 exercise price is disclosed and noted as fully vested and currently exercisable.

Was the sale a one-off trade or part of a pre-arranged plan?

Part of a pre-arranged Rule 10b5-1 trading plan, as explicitly stated in the filing.